Actively Recruiting
Clinical Study Evaluating the Effect of Losartan
Led by Tanta University · Updated on 2024-08-06
90
Participants Needed
1
Research Sites
108 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The pancreas is two organs packaged into one. The islets of Langerhans serve critical endocrine functions, and the exocrine portion is a major source of enzymes that are essential for digestion. Pancreatic cancer (PC) is more commonly referred to as pancreatic infiltrating ductal adenocarcinoma in addition to being the second leading cause of cancer death in the United States, after lung cancer in 2020. Whereas pancreatic cancer is the seventh cause of death from cancer in Asia in 2020. Although it is substantially less common than the other malignancies, pancreatic carcinoma is near the top of the list of killers because it is a highly aggressive carry.
CONDITIONS
Official Title
Clinical Study Evaluating the Effect of Losartan
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male and female pancreatic cancer patients aged 250 years old.
- Hypertensive patients with blood pressure 2140/90 mm Hg.
- Patients with histologically confirmed metastatic pancreatic adenocarcinoma or locally advanced pancreatic cancer.
- Patients who have signed an informed consent form.
You will not qualify if you...
- Patients with serious systemic disorders affecting the heart, kidneys, liver, or lungs.
- Pregnant or breastfeeding women and women who can become pregnant.
- Patients who have received systemic fluoropyrimidine therapy in the past 10 years.
- Patients with severe allergic reactions to fluoropyrimidine therapy, 5-fluorouracil, irinotecan, oxaliplatin, losartan, or any monoclonal antibody.
- Patients with active or suspected autoimmune diseases like psoriasis.
- Patients who tested positive for hepatitis B or C, HIV, or AIDS.
- Patients who received live or live attenuated vaccines, including intranasal influenza vaccines, within 30 days before starting the study therapy.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Tanta University Hospital
Tanta, Egypt
Actively Recruiting
Research Team
M
Mona Abd El-Rafea Mohamed, M.D
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here